Outcomes among patients with mantle cell lymphoma post-covalent btk inhibitor therapy in the united states: a real- world electronic medical records study

HIGHLIGHTS

• who: Lisa M. Hess and colleagues from the Eli Lilly and Company, India have published the Article: Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real- World Electronic Medical Records Study, in the Journal: Advances in Hematology 5 of October/31,/2020
• what: Tis study was designed to examine patient characteristics current treatment patterns and clinical outcomes using a real-world database to evaluate how MCL is currently managed post-cBTKi therapy in the U.S. Methods. Variation in care by practice setting should be studied . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.